BIO-RAD LABORATORIES INC

20 February, 2025

Bio-Rad Laboratories to Acquire Stilla Technologies for $225 Million, Aiming to Boost Digital PCR Capabilities Amid Market Challenges

Bio-Rad Laboratories (BIO) is poised for a significant shift in its operational capabilities with its binding agreement to acquire Stilla Technologies, a prominent player in the digital PCR space. Thi...
Read More

19 February, 2025

Bio-Rad Laboratories to Acquire Stilla Technologies for $225 Million, Aiming to Boost Digital PCR Portfolio Amid Financial Challenges

Bio-Rad Laboratories (BIO) is making a strategic move by acquiring Stilla Technologies, a French digital PCR company, for approximately $225 million. This acquisition, set to enhance Bio-Rad's digital...
Read More

14 February, 2025

Bio-Rad Laboratories Reports Strong Third-Quarter Earnings, Exceeding Estimates with Adjusted EPS of $2.01 and Revenues of $649.7 Million

Bio-Rad Laboratories (BIO) has recently showcased a remarkable performance in its third-quarter 2024 financial results, reporting an adjusted earnings per share (EPS) of $2.01, which exceeded the Zack...
Read More

13 February, 2025

Bio-Rad Laboratories Reports Strong Third-Quarter Earnings, Exceeding Estimates with Adjusted EPS of $2.01 and Revenues of $649.7 Million

Bio-Rad Laboratories (BIO) has recently showcased a remarkable performance in its third-quarter 2024 financial results, reporting an adjusted earnings per share (EPS) of $2.01, which exceeded the Zack...
Read More